Literature DB >> 10027684

Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia.

O Junghard1, K Lauritsen, N J Talley, I K Wiklund.   

Abstract

The diary card as a measure of the severity of pain or discomfort in the stomach on a 7 graded scale was validated using data from a randomised placebo controlled clinical trial in patients with non-ulcer dyspepsia (NUD). The diary card measure was compared to two other measures: a symptom question in a gastro-intestinal symptom questionnaire and a symptom severity rating made by the investigator based on an interview with the patient at the clinical visit. The reliability coefficient for the mean of the diary card scores from 7 consecutive days was estimated to 0.71. The mean of the scores from 7 consecutive days was approximately as sensitive to change as the other two measures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10027684     DOI: 10.1080/11024159850191355

Source DB:  PubMed          Journal:  Eur J Surg Suppl        ISSN: 1102-416X


  18 in total

1.  Best practice in symptom assessment: a review.

Authors:  E McColl
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Development and validation of a cross-cultural questionnaire to evaluate nonulcer dyspepsia: the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ).

Authors:  Guilherme Becker Sander; Luiz Edmundo Mazzoleni; Carlos Fernando Magalhães Francesconi; André Castagna Wortmann; Eduardo André Ott; Alexandro Theil; Piccoli Vicenzo Da Cruz; Angela Cristiane Da Silva; Leandro Oliveira; Simone Beheregaray; Simone Matioti; Gustavo Somm; José Roberto Goldim
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Authors:  Nicholas J Talley; G Richard Locke; Yuri A Saito; Ann E Almazar; Ernest P Bouras; Colin W Howden; Brian E Lacy; John K DiBaise; Charlene M Prather; Bincy P Abraham; Hashem B El-Serag; Paul Moayyedi; Linda M Herrick; Lawrence A Szarka; Michael Camilleri; Frank A Hamilton; Cathy D Schleck; Katherine E Tilkes; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

4.  Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.

Authors:  Nicholas J Talley; G Richard Locke; Linda M Herrick; Vickie M Silvernail; Charlene M Prather; Brian E Lacy; John K DiBaise; Colin W Howden; Darren M Brenner; Ernest P Bouras; Hashem B El-Serag; Bincy P Abraham; Paul Moayyedi; Alan R Zinsmeister
Journal:  Contemp Clin Trials       Date:  2012-02-10       Impact factor: 2.226

5.  Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.

Authors:  N J Talley; J Janssens; K Lauritsen; I Rácz; E Bolling-Sternevald
Journal:  BMJ       Date:  1999-03-27

6.  A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire.

Authors:  Luigi Gatta; Paul Moayyedi; Cesare Tosetti; Nimish Vakil; Enzo Ubaldi; Patrizia Barsanti; Giulia Fiorini; Valentina Castelli; Carlo Gargiulo; Paolo Lucarini; Maurizio Lera; Enkleda Kajo; Francesco Di Mario; Dino Vaira
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

Review 7.  Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature.

Authors:  A M Rentz; C Battista; E Trudeau; R Jones; P Robinson; S Sloan; S Mathur; L Frank; D A Revicki
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.

Authors:  Naoki Chiba; Sander J O Veldhuyzen Van Zanten; Paul Sinclair; Ralph A Ferguson; Sergio Escobedo; Eileen Grace
Journal:  BMJ       Date:  2002-04-27

9.  Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

Authors:  Christopher J Hawkey; Lars-Erik Svedberg; Jørgen Naesdal; Claire Byrne
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

Authors:  Kouichi Sakurai; Akihito Nagahara; Kazuhiko Inoue; Junichi Akiyama; Katsuhiro Mabe; Junichi Suzuki; Yasuki Habu; Akihiro Araki; Tsuyoshi Suzuki; Katsuaki Satoh; Haruhiko Nagami; Ryosaku Harada; Nobuo Tano; Masayasu Kusaka; Yasuhiko Fujioka; Toshikatsu Fujimura; Nobuyuki Shigeto; Tsuneyo Oumi; Jun Miwa; Hiroto Miwa; Kazuma Fujimoto; Yoshikazu Kinoshita; Ken Haruma
Journal:  BMC Gastroenterol       Date:  2012-05-01       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.